To describe the following outcome measures and review their measurement properties (validity, reliability, responsiveness to change, and MID): Short form (36) health survey (SF-36) Control of Eating Questionnaire (CoEQ) Diabetes Treatment-Related Quality of Life (DTR-QOL) Impact of Weight on Quality of Life-Lite clinical trials version (IWQoL-Lite-CT) Diabetes Treatment Satisfaction Questionnaire (DTSQ) A focused literature search was conducted to identify the psychometric properties and minimally important difference (MID) of each of the stated outcome measures
References Angl, S., Engblom, J., Eriksson, T., Kautiainen, S., Saha, M.-T., Lindfors, P., Lehtinen, M., & Rimpel, A
PMC 6740277
But the basic principle of these drugs mimicking, and effectively boosting, the natural functions of GLP-1 has remained the same, according to Andrea Coviello, an endocrinologist and medical director of the Medical Weight Program at the University of North Carolina